EI- Nile Co. for Pharmaceuticals and Chemical Industries (CASE: NIPH)
Health Care · Pharmaceuticals · EG
EGP331.03
+1.70% today · +303.7% 1Y
EI- Nile Co. for Pharmaceuticals and Chemical Industries (CASE: NIPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $316.17M.
Over the last twelve months the share price has gained 303.7%, trading between 80.21 and 516.96.
Tweenvest scores EI- Nile Co. for Pharmaceuticals and Chemical Industries across four factors: quality 69/100, value 15/100, growth 12/100, dividend 100/100. Its strongest factor is dividend.
NIPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $316.17M
- Revenue (TTM)
- $41.01M
- P/E
- 68.93
- EPS
- 4.80
- Dividend yield
- 0.60%
- Beta (5Y)
- 0.67
- 52-week high
- EGP516.96
- 52-week low
- EGP80.21
- Avg volume (3M)
- —
- Shares outstanding
- 50.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Guhan Pharmaceutical Group Co., Ltd.SZSE: 000590 | $324.87M | CN¥9.10 | +1.45% |
| Gulf Pharmaceutical Industries P.S.C.ADX: JULPHAR | $323.95M | AED1.03 | -0.96% |
| Abbott Laboratories (Pakistan) LimitedKASE: ABOT | $323.17M | PKRs915.21 | +0.21% |
| Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,LtdSZSE: 301130 | $320.87M | CN¥28.51 | +1.14% |
| Standard Chemical & Pharmaceutical Co., Ltd.TWSE: 1720 | $314.56M | NT$56.10 | +0.36% |
| SNDL Inc.NasdaqCM: SNDL | $308.34M | $1.23 | -0.81% |
| Guiyang Xintian Pharmaceutical Co.,Ltd.SZSE: 002873 | $303.03M | CN¥8.55 | +2.03% |
| Lavipharm S.A.ATSE: LAVI | $301.39M | €1.57 | -0.13% |
Figures last refreshed Oct 4, 2026.